Bronchiectasis in renal transplant patients: a cross-sectional study.
Bronchiectasis
CT scan
Extended culture
Quality of life
Renal transplantation
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
13 Feb 2024
13 Feb 2024
Historique:
received:
05
09
2022
accepted:
29
01
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
13
2
2024
Statut:
epublish
Résumé
Bronchiectasis is a chronic airway disease characterized by permanent and irreversible abnormal dilatation of bronchi. Several studies have reported the development of bronchiectasis after renal transplantation (RT), but no prospective study specifically assessed bronchiectasis in this population. This study aimed to compare features of patients with bronchiectasis associated with RT to those with idiopathic bronchiectasis. Nineteen patients with bronchiectasis associated with RT (RT-B group) and 23 patients with idiopathic bronchiectasis (IB group) were prospectively included in this monocentric cross-sectional study. All patients underwent clinical, functional, laboratory, and CT scan assessments. Sputum was collected from 25 patients (n = 11 with RT-B and n = 14 with IB) and airway microbiota was analyzed using an extended microbiological culture. Dyspnea (≥ 2 on mMRC scale), number of exacerbations, pulmonary function tests, total bronchiectasis score, severity and prognosis scores (FACED and E-FACED), and quality of life scores (SGRQ and MOS SF-36) were similar in the RT-B and IB groups. By contrast, chronic cough was less frequent in the RT-B group than in the IB group (68% vs. 96%, p = 0.03). The prevalence and diversity of the airway microbiota in sputum were similar in the two groups. Clinical, functional, thoracic CT scan, and microbiological characteristics of bronchiectasis are overall similar in patients with IB and RT-B. These results highlight that in RT patients, chronic respiratory symptoms and/or airway infections should lead to consider the diagnosis of bronchiectasis. Further studies are required to better characterize the pathophysiology of RT-B including airway microbiota, its incidence, and impact on therapeutic management.
Sections du résumé
BACKGROUND
BACKGROUND
Bronchiectasis is a chronic airway disease characterized by permanent and irreversible abnormal dilatation of bronchi. Several studies have reported the development of bronchiectasis after renal transplantation (RT), but no prospective study specifically assessed bronchiectasis in this population. This study aimed to compare features of patients with bronchiectasis associated with RT to those with idiopathic bronchiectasis.
METHODS
METHODS
Nineteen patients with bronchiectasis associated with RT (RT-B group) and 23 patients with idiopathic bronchiectasis (IB group) were prospectively included in this monocentric cross-sectional study. All patients underwent clinical, functional, laboratory, and CT scan assessments. Sputum was collected from 25 patients (n = 11 with RT-B and n = 14 with IB) and airway microbiota was analyzed using an extended microbiological culture.
RESULTS
RESULTS
Dyspnea (≥ 2 on mMRC scale), number of exacerbations, pulmonary function tests, total bronchiectasis score, severity and prognosis scores (FACED and E-FACED), and quality of life scores (SGRQ and MOS SF-36) were similar in the RT-B and IB groups. By contrast, chronic cough was less frequent in the RT-B group than in the IB group (68% vs. 96%, p = 0.03). The prevalence and diversity of the airway microbiota in sputum were similar in the two groups.
CONCLUSION
CONCLUSIONS
Clinical, functional, thoracic CT scan, and microbiological characteristics of bronchiectasis are overall similar in patients with IB and RT-B. These results highlight that in RT patients, chronic respiratory symptoms and/or airway infections should lead to consider the diagnosis of bronchiectasis. Further studies are required to better characterize the pathophysiology of RT-B including airway microbiota, its incidence, and impact on therapeutic management.
Identifiants
pubmed: 38350996
doi: 10.1186/s40001-024-01701-1
pii: 10.1186/s40001-024-01701-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120Informations de copyright
© 2024. The Author(s).
Références
Polverino E, Pieter C, McDonell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Canton R, Torres A, Dimakou K, De Soriza A, Hill AT, Hawortj CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.
pubmed: 28889110
doi: 10.1183/13993003.00629-2017
Gao YH, Guan WJ, Liu SX, Wang L, Cui JJ, Chen RC, Zhang GJ. Aetiology of bronchiectasis in adults: a systematic literature review. Respirology. 2016;21(8):1376–83.
pubmed: 27321896
doi: 10.1111/resp.12832
Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome and disease heterogeneity. Lancet. 2018;392(10150):880–90.
pubmed: 30215383
pmcid: 6173801
doi: 10.1016/S0140-6736(18)31767-7
Saadi Imam J, Duarte AG. Non-CF bronchiectasis: orphan disease no longer. Respir Med. 2020;166: 105940.
doi: 10.1016/j.rmed.2020.105940
Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest. 2005;128(2):739–45.
pubmed: 16100162
doi: 10.1378/chest.128.2.739
Terpstra LC, Biesenbeek S, Altenburg J, Boersma WG. Aetiology and disease severity are among the determinants of quality of life in bronchiectasis. Clin Respir J. 2019;13(8):521–9.
pubmed: 31295770
doi: 10.1111/crj.13054
Wilson CB, Jones PW, O’Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997;10:1754–60.
pubmed: 9272915
doi: 10.1183/09031936.97.10081754
Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goemine PC, Hill AT, Fardon TC, Obradovic D, Mc Donell MJ. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. Am J Respir Crit Care Med. 2018;197(11):1410–20.
pubmed: 29357265
doi: 10.1164/rccm.201711-2202OC
Richardson H, Dicker AJ, Barclay H, Chalmers JD. The microbiome in bronchiectasis. Eur Respir Rev. 2019;28(153): 190048.
pubmed: 31484665
pmcid: 9489022
doi: 10.1183/16000617.0048-2019
Aksamit TR, O’Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, Johnson M, Eden E, Griffith D, Knowles M, Metersky M, Salathe M, Thomashow B, Tino G, Turino G, Carretta B, Daley CL. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017;151(5):982–92.
pubmed: 27889361
doi: 10.1016/j.chest.2016.10.055
Amati F, Simonetta E, Gramegna A, Tarsia P, Contarini M, Blasi F, Aliberti S. The biology of pulmonary exacerbations in bronchiectasis. Eur Respir Rev. 2019;28(154): 190055.
pubmed: 31748420
pmcid: 9488527
doi: 10.1183/16000617.0055-2019
Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bonchiectasis. Nat Rev Dis Prim. 2018;4(1):45.
pubmed: 30442957
doi: 10.1038/s41572-018-0042-3
Pijnenburg MWH, Cransberg K, Wolff E, Bouquet J, Merkus PJFM. Bronchiectasis in children after renal or liver transplantation: a report of five cases. Pediatr Transplant. 2004;8(1):71–4.
pubmed: 15009844
doi: 10.1046/j.1397-3142.2003.00130.x
Boddana P, Webb LH, Unsworth J, Brealey M, Bingham C, Harper SJ. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon? Clin Transplant. 2011;25(3):417–9.
pubmed: 20438577
doi: 10.1111/j.1399-0012.2010.01255.x
Rook M, Postma DS, van der Jagt EJ, van Minnen CA, van der Heide JJH, Ploeg RJ, et al. Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship. Transplantation. 2006;81(2):287–9.
pubmed: 16436974
doi: 10.1097/01.tp.0000188638.28003.96
Cransberg K, Marlies Cornelissen EA, Davin JC, Van Hoeck KJ, Lilien MR, Stijnen T, Nauta J. Improved outcome of pediatric kidney transplantations in the Netherlands—effect of the introduction of mycophenolate mofetil? Pediatr Transplant. 2005;9(1):104–11.
pubmed: 15667622
doi: 10.1111/j.1399-3046.2005.00271.x
Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. BMC Pulm Med. 2015;15:141.
pubmed: 26545860
pmcid: 4636796
doi: 10.1186/s12890-015-0133-9
Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher PW, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR. British Thoracic Society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1–69. https://doi.org/10.1136/thoraxjnl-2018-212463 .
doi: 10.1136/thoraxjnl-2018-212463
pubmed: 30545985
Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, Nivens C, Ghafouri M, McDonald J, Tetzlaff K. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545–55.
pubmed: 18662868
doi: 10.1016/j.rmed.2008.06.009
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
pubmed: 6880820
doi: 10.1111/j.1600-0447.1983.tb09716.x
Olveira C, Olveira G, Gaspar I, Dorado A, Cruz I, Soriguer F, Quittner AL, Espildora F. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res. 2013;22:597–605.
pubmed: 22544417
doi: 10.1007/s11136-012-0188-5
Jones PW, Quirk FH, Baveystock CM. The St George’s respiratory questionnaire. Respir Med. 1991;85(Suppl B):25–31 (discussion 33–37).
pubmed: 1759018
doi: 10.1016/S0954-6111(06)80166-6
Wilson CB, Jones PW, O’Leary CJ, Cole PJ, Wilson R. Validation of the St. George’s respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):536–41.
pubmed: 9279236
doi: 10.1164/ajrccm.156.2.9607083
Perneger TV, Leplège A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-item short form health survey (SF-36) in young healthy adults. J Clin Epidemiol. 1995;48(8):1051–60.
pubmed: 7775992
doi: 10.1016/0895-4356(94)00227-H
Lee A, Button BM, Ellis S, et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009;103(5):780–5.
pubmed: 19070473
doi: 10.1016/j.rmed.2008.11.005
Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O’Donnell A, Aksamit T, EMBARC/BRR Definitions Working Group. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6):1700051.
pubmed: 28596426
doi: 10.1183/13993003.00051-2017
Martınez-Garcıa MA, De Gracia J, Vendrell Relat M, Giron RM, Maiz Carro L, De la Rosa CD, Olveira C. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357–67.
pubmed: 24232697
doi: 10.1183/09031936.00026313
Martinez-Garcia MA, Athanazio RA, Giron R, Maiz-Carro L, de la Rosa D, Olveira C, De Gracia J, Vendrell M, Prados-Sanchez C, Gramblicka G, Corso Pereira M, Lundgre FL, De Figueiredo MF, Arancibia F, Rached SZ. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275–84.
pubmed: 28182132
pmcid: 5279836
doi: 10.2147/COPD.S121943
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–772.
pubmed: 18195376
doi: 10.1148/radiol.2462070712
Ooi GC, Khong PL, Chan-Yeung M, Ho JCM, Chan PKS, Lee JCK, Tsang KWT. High-resolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology. 2002;225(3):663–72.
pubmed: 12461244
doi: 10.1148/radiol.2253011575
Paggiaro PL, Djukanovic R, Maestrelli P, Sterk PJ. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s.
pubmed: 12361361
Guiot J, Demarche S, Henket M, Paulus V, Graff S, Schleich F, Corhay JL, Louis R, Moermans C. Methodology for sputum induction and laboratory processing. J Vis Exp. 2017;130:56612.
Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD. A Comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602–11.
pubmed: 26356317
Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–85.
pubmed: 24328736
pmcid: 3977711
doi: 10.1164/rccm.201309-1575OC
McDonnell MJ, Anwar GA, Rutherford RM, De Soyza A, Worthy S, Corris PA, Lordan JL, Bourke S, Afolabi G, Ward C, Middleton P, Middleton D. Lack of association between KIR and HLA-C type and susceptibility to idiopathic bronchiectasis. Respir Med. 2014;108(8):1127–33.
pubmed: 24986480
doi: 10.1016/j.rmed.2014.05.017
Radovanovic D, Santus P, Blasi F, Sotgiu G, D’Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S. A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018;145:120–9.
pubmed: 30509700
doi: 10.1016/j.rmed.2018.10.031
King PT, Holdsworth SR, Freezer NJ, Villanueva E, Farmer MW, Guy P, Holmes PW. Lung diffusing capacity in adult bronchiectasis: a longitudinal study. Respir Care. 2010;55(12):1686–92.
pubmed: 21122177
Bush A, Gabriel R. Pulmonary function in chronic renal failure: effects of dialysis and transplantation. Thorax. 1991;46(6):424–8. https://doi.org/10.1136/thx.46.6.424 .
doi: 10.1136/thx.46.6.424
pubmed: 1858080
pmcid: 463189
Kalender B, Erk M, Pekpak MA, Apaydin S, Ataman R, Serdengeçti K, Sariyar M, Erek E. The effect of renal transplantation on pulmonary function. Nephron. 2002;90(1):72–7.
pubmed: 11744808
doi: 10.1159/000046317
Liu J, Zhong X, He Z, Wei L, Zheng X, Zhang J, Bai J, Zhong W, Zhong D. Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasis. Mediat Inflamm. 2014;2014: 708608.
doi: 10.1155/2014/708608
Au E, Wong G, Chapman JR. Cancer in kidney transplant recipients. Nat Rev Nephrol. 2018;14(8):508–20. https://doi.org/10.1038/s41581-018-0022-6 .
doi: 10.1038/s41581-018-0022-6
pubmed: 29802400
Alonso A, Oliver J. Causes of death and mortality risk factors. Nephrol Dial Transplant. 2004;19(Suppl 3):iii8–10.
pubmed: 15192128
Hoyo I, Linares L, Cervera C, Almela M, Marcos MA, Sanclemente G, Cofán F, Ricart MJ, Moreno A. Epidemiology of pneumonia in kidney transplantation. Transplant Proc. 2010;42(8):2938–40.
pubmed: 20970576
doi: 10.1016/j.transproceed.2010.07.082
Czyżewski Ł, Frelik P, Wyzgał J, Szarpak Ł. Evaluation of quality of life and severity of depression, anxiety, and stress in patients after kidney transplantation. Transplant Proc. 2018;50(6):1733–7.
pubmed: 30056891
doi: 10.1016/j.transproceed.2018.04.026
Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax. 2013;68(8):731–7.
pubmed: 23564400
doi: 10.1136/thoraxjnl-2012-203105
Cox MJ, Turek EM, Hennessy C, Mirza GK, James PL, Coleman M, Jones A, Wilson R, Bilton D, Cookson WO, Moffatt MF, Loebinger MR. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients. PLoS ONE. 2017;12(2): e0170622.
pubmed: 28170403
pmcid: 5295668
doi: 10.1371/journal.pone.0170622
Li L, Zhang J, Li Z, Zhang C, Bi J, Zhou J, Song Y, Shao C. Airway microbiota is associated with the severity of non-CF bronchiectasis. Clin Respir J. 2021;15(2):154–62.
pubmed: 32966701
doi: 10.1111/crj.13279
Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013;187(10):1118–26.
pubmed: 23348972
pmcid: 3734618
doi: 10.1164/rccm.201210-1937OC
Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182(8):1058–64.
pubmed: 20522788
pmcid: 2970846
doi: 10.1164/rccm.200912-1853OC
Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol. 2010;45(6):536–40.
pubmed: 20503277
doi: 10.1002/ppul.21138
Alexandre Y, Le Blay G, Boisramé-Gastrin S, Le Gall F, Héry-Arnaud G, Gouriou S, Vallet S, Le Berre R. Probiotics: a new way to fight bacterial pulmonary infections? Med Mal Infect. 2014;44(1):9–17.
pubmed: 23820129
doi: 10.1016/j.medmal.2013.05.001
Pulvirenti G, Parisi GF, Giallongo A, Papale M, Manti S, Savasta S, Licari A, Marseglia GL, Leonardi S. Lower airway microbiota. Front Pediatr. 2019;7:393.
pubmed: 31612122
pmcid: 6776601
doi: 10.3389/fped.2019.00393
Fangous MS, Alexandre Y, Hymery N, Gouriou S, Arzur D, Blay GL, Berre RL. Lactobacilli intra-tracheal administration protects from Pseudomonas aeruginosa pulmonary infection in mice—a proof of concept. Benef Microbes. 2019;10(8):893–900.
pubmed: 31965833
doi: 10.3920/BM2019.0069
Khailova L, Baird CH, Rush AA, McNamee EN, Wischmeyer PE. Lactobacillus rhamnosus GG improves outcome in experimental pseudomonas aeruginosa pneumonia: potential role of regulatory T cells. Shock. 2013;40(6):496–503.
pubmed: 24240593
pmcid: 5592098
doi: 10.1097/SHK.0000000000000066
Alvarez S, Herrero C, Bru E, Perdigon G. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J Food Prot. 2001;64(11):1768–74.
pubmed: 11726157
doi: 10.4315/0362-028X-64.11.1768
Driscoll JA, Bhalla S, Liapis H, Ibricevic A, Brody SL. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis. Chest. 2008;133(5):1181–8.
pubmed: 18263686
doi: 10.1378/chest.07-2147
Moua T, Zand L, Hartman RP, Hartman TE, Qin D, Peikert T, Qian Q. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS ONE. 2014;9(4): e93674.
pubmed: 24747723
pmcid: 3991584
doi: 10.1371/journal.pone.0093674
Spinou A, Siegert RJ, Guan WJ, Patel AS, Gosker HR, Lee KK, Elston C, Loebinger MR, Wilson R, Garrod R, Birring SS. The development and validation of the bronchiectasis health questionnaire. Eur Respir J. 2017;49(5):1601532.
pubmed: 28495688
doi: 10.1183/13993003.01532-2016